A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients.

In conclusion, our results demonstrated that this 10-lncRNA signature effectively grouped patients at low and high risk of disease recurrence. PMID: 31429520 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31429520?dopt=Abstract

Source: J Cell Mol Med - August 19, 2019 Category: Molecular Biology Authors: Tang J, Ren J, Cui Q, Zhang D, Kong D, Liao X, Lu M, Gong Y, Wu G Tags: J Cell Mol Med Source Type: research